MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 26.094

Change

+0.39 (+1.50)%

Market Cap

N/A

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+0.06 (+0.11%)

USD 45.40B
QQQM Invesco NASDAQ 100 ETF

+5.31 (+2.84%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.99 (+1.99%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

+2.07 (+1.82%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

+0.16 (+0.94%)

USD 16.14B
SNDK Sandisk Corp

+1.93 (+6.36%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

+0.54 (+6.59%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

+2.34 (+7.53%)

USD 3.04B
ETHA iShares Ethereum Trust ETF

-0.18 (-1.33%)

USD 2.37B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.14% 60% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.14% 58% F 67% D+
Trailing 12 Months  
Capital Gain -5.13% 27% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.13% 25% F 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.73% 34% F 39% F
Dividend Return -0.73% 27% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.68% 81% B- 96% N/A
Risk Adjusted Return -19.79% 22% F 26% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector